Regulation of murine natural killer cell commitment

Frontiers in Immunology

Volumn 4, Issue JAN, 2013, Pages

  Huntington, Nicholas D ^a,b   Nutt, Stephen L ^a,b   Carotta, Sebastian ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Development; Differentiation; ID2; Innate lymphocytes; Natural killer cells; NFIL3; Pre pro NK cells; Transcription factors

Indexed keywords

EID: 84874278105     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00014     Document Type: Article

References (61)

1. Aringer, M., Hofmann, S. R., Frucht, D. M., Chen, M., Centola, M., Morinobu, A., et al. (2003). Characterization and analysis of the proximal Janus kinase 3 promoter. J. Immunol. 170,6057-6064.
2. Barton, K., Muthusamy, N., Fischer, C., Ting, C. N., Walunas, T. L., Lanier, L. L., et al. (1998). The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity 9, 555-563.
3. Basham, B., Sathe, M., Grein, J., McClanahan, T., D'Andrea, A., Lees, E., et al. (2008). In vivo identification of novel STAT5 target genes. Nucleic Acids Res. 36, 3802-3818.
4. Boos, M. D., Yokota, Y., Eberl, G., and Kee, B. L. (2007). Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity. J. Exp. Med. 204, 1119- 1130.
5. Carotta, S., Brady, J., Wu, L., and Nutt, S. L. (2006). Transient Notch signaling induces NK cell potential in Pax5-deficient pro-B cells. Eur. J. Immunol. 36,3294-3304.
6. Carotta, S., Dakic, A., D'Amico, A., Pang, S. H., Greig, K. T., Nutt, S. L., et al. (2010a). The transcription factor PU.1 controls dendritic cell development and Flt3 cytokine receptor expression in a dose-dependent manner. Immunity 32, 628-641.
7. Carotta, S., Wu, L., and Nutt, S. L. (2010b). Surprising new roles for PU.1 in the adaptive immune response. Immunol Rev. 238, 63-75.
8. Carotta, S., Pang, S. H., Nutt, S. L., and Belz, G. T. (2011). Identification of the earliest NK-cell precursor in the mouse BM. Blood 117, 5449-5452.
9. Colucci, F., Samson, S. I., DeKoter, R. P., Lantz, O., Singh, H., and Di Santo, J. P. (2001). Differential requirement for the transcription factor PU.1 in the generation of natural killer cells versus B and T cells. Blood 97,2625-2632.
10. DeKoter, R. P., Lee, H. J., and Singh, H. (2002). PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors. Immunity 16, 297-309.
11. Eckelhart, E., Warsch, W., Zebedin, E., Simma, O., Stoiber, D., Kolbe, T., et al. (2011). A novel Ncr 1 -Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. Blood 117,1565-1573.
12. Fathman, J. W., Bhattacharya, D., Inlay, M. A., Seita, J., Karsunky, H., and Weissman, I. L. (2011). Identification of the earliest natural killer cell-committed progenitor in murine bone marrow. Blood 118, 5439-5447.
13. Gascoyne, D. M., Long, E., Veiga-Fernandes, H., de Boer, J., Williams, O., Seddon, B., et al. (2009). The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development. Nat. Immunol. 10, 1118-1124.
14. Georgopoulos, K., Bigby, M., Wang, J. H., Molnar, A., Wu, P., Winandy, S., et al. (1994). The Ikaros gene is required for the development of all lymphoid lineages. Cell 79, 143-156.
15. Georgopoulos, K., Moore, D. D., and Derfler, B. (1992). Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment. Science 258, 808-812.
16. Georgopoulos, K., Winandy, S., and Avitahl, N. (1997). The role of the Ikaros gene in lymphocyte development and homeostasis. Annu. Rev. Immunol. 15, 155-176.
17. Gordon, S. M., Chaix, J., Rupp, L. J., Wu, J., Madera, S., Sun, J. C., et al. (2012). The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity 36, 55-67.
18. Haller, O., Kiessling, R., Orn, A., and Wigzell, H. (1977). Generation of natural killer cells: an autonomous function of the bone marrow. J. Exp. Med. 145, 1411-1416.
19. Heemskerk, M. H., Blom, B., Nolan, G., Stegmann, A. P., Bakker, A. Q., Weijer, K., et al. (1997). Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3. J. Exp. Med. 186, 1597-1602.
20. Hendriks, R. W., Nawijn, M. C., Engel, J. D., van Doorninck, H., Grosveld, E, and Karis, A. (1999). Expression of the transcription factor GATA-3 is required for the development of the earliest T cell progenitors and correlates with stages of cellular proliferation in the thymus. Eur. J. Immunol. 29,1912-1918.
21. Hesslein, D. G., and Lanier, L. L. (2011). Transcriptional control of natural killer cell development and function. Adv. Immunol. 109,45-85.
22. Hosoya, T., Kuroha, T., Moriguchi, T., Cummings, D., Maillard, I., Lim, K. C., et al. (2009). GATA-3 is required for early T lineage progenitor development. J. Exp. Med. 206,2987-3000.
23. Huntington, N. D., Tabarias, H., Fairfax, K., Brady, J., Hayakawa, Y., Degli-Esposti, M. A., et al. (2007a). NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation. J. Immunol. 178,4764-4770.
24. Huntington, N. D., Vosshenrich, C. A., and Di Santo, J. P. (2007b). Developmental pathways that generate natural-killer-cell diversity in mice and humans. Nat. Rev. Immunol. 7, 703-714.
25. Imada, K., Bloom, E. T., Nakajima, H., Horvath-Arcidiacono, J. A., Udy, G. B., Davey, H. W., et al. (1998). Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity. J. Exp. Med. 188, 2067-2074.
26. + dendritic cell lineages. EMBO J. 30, 2690-2704.
27. Kamizono, S., Duncan, G. S., Sei-del, M. G., Morimoto, A., Hamada, K., Grosveld, G., et al. (2009). Mak, Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo. J. Exp. Med. 206,2977-2986.
28. Kondo, M., Weissman, I. L., and Akashi, K. (1997). Identification of clono-genic common lymphoid progenitors in mouse bone marrow. Cell 91, 661-672.
29. Li, L., Leid, M., and Rothenberg, E. V. (2010). An early T cell lineage commitment checkpoint dependent on the transcription factor Bcl11b. Science 329, 89-93.
30. Male, V., Nisoli, I., Gascoyne, D. M., and Brady, H. J. (2012). E4BP4: an unexpected player in the immune response. Trends Immunol. 33, 98-102.
31. Malin, S., McManus, S., and Busslinger, M. (2010). STAT5 in B cell development and leukemia. Curr. Opin. Immunol. 22, 168-176.
32. McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., et al. (1996). Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBOJ. 15,5647-5658.
33. Mold, J. E., and McCune, J. M. (2011). At the crossroads between tolerance and aggression: revisiting the "layered immune system" hypothesis. Chimerism 2, 35-41.
34. Mold, J. E., and McCune, J. M. (2012). Immunological tolerance during fet al development: from mouse to man. Adv. Immunol. 115, 73-111.
35. Morgan, B., Sun, L., Avitahl, N., Andrikopoulos, K., Ikeda, T., Gon-zales, E., et al. (1997). Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation. EMBO J. 16,2004-2013.
36. Nakajima, H., Liu, X. W., Wynshaw-Boris, A., Rosenthal, L. A., Imada, K., Finbloom, D. S., et al. (1997). An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor alpha chain induction. Immunity 7, 691-701.
37. Nutt, S. L., Eberhard, D., Horcher, M., Rolink, A. G., and Busslinger, M. (2001). Pax5 determines the identity of B cells from the beginning to the end of B-lymphopoiesis. Int. Rev. Immunol. 20, 65-82.
38. Nutt, S. L., and Kee, B. L. (2007). The transcriptional regulation of B cell lineage commitment. Immunity 26, 715-725.
39. Nutt, S. L., Metcalf, D., D'Amico, A., Polli, M., and Wu, L. (2005). Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors. J. Exp. Med. 201, 221-231.
40. O'Shea, J. J., and Plenge, R. (2012). JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity 36, 542-550.
41. Park, S. Y., Saijo, K., Takahashi, T., Osawa, M., Arase, H., Hirayama, N., et al. (1995). Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity 3, 771-782.
42. Payne, K. J., Huang, G., Sahakian, E., Zhu, J. Y., Barteneva, N. S., Barsky, L. W., et al. (2003). isoform x is selectively expressed in myeloid differentiation. J. Immunol. 170, 3091-3098.
43. Phillips, J. H., Hori, T., Nagler, A., Bhat, N., Spits, H., and Lanier, L. L. (1992). Ontogeny of human natural killer (NK) cells: fet al NK cells mediate cytolytic function and express cyto-plasmic CD3 epsilon,delta proteins. J. Exp. Med. 175, 1055-1066.
44. Quong, M. W., Romanow, W. J., and Murre, C. E. (2002). protein function in lymphocyte development. Annu. Rev. Immunol. 20, 301-322.
45. Ramirez, K., Chandler, K. J., Spauld-ing, C., Zandi, S., Sigvardsson, M., Graves, B. J., et al. (2012). Gene deregulation and chronic activation in natural killer cells deficient in the transcription factor ETS1. Immunity 36,921-932.
46. Rosmaraki, E. E., Douagi, I., Roth, C., Colucci, F., Cumano, A., and Di Santo, J. P. (2001). Identification of committed NK cell progenitors in adult murine bone marrow. Eur. J. Immunol. 31, 1900-1909.
47. Samson, S. I., Richard, O.,Tavian, M., Ranson, T., Vosshenrich, C. A., Colucci, F., et al. (2003). GATA-3 promotes maturation, IFN-gamma production, and liver-specific homing of NK cells. Immunity 19, 701-711.
48. Schotte, R., Dontje, W., Nagasawa, M., Yasuda, Y., Bakker, A. Q., Spits, H., et al. (2010). Synergy between IL-15 and Id2 promotes the expansion of human NK progenitor cells, which can be counteracted by the E protein HEB required to drive T cell development. J. Immunol. 184, 6670-6679.
49. Scott, E. W., Fisher, R. C., Olson, M. C., Kehrli, E. W., Simon, M. C., and Singh, H. (1997). PU.1 functions in a cell-autonomous manner to control the differentiation of multi-potential lymphoid-myeloid progenitors. Immunity 6, 437-447.
50. Scott, E. W., Simon, M. C., Anastasi, J., and Singh, H. (1994). Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265,1573-1517.
51. Spain, L. M., Guerriero, A., Kunjibettu, S., and Scott, E. W. (1999).T cell development in PU.1-deficient mice. J. Immunol. 163,2681-2687.
52. Takeda, K., Cretney, E., Hayakawa, Y., Ota, T., Akiba, H., Ogasawara, K., et al. (2005). TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver. Blood 105,2082-2089.
53. Tang, Y., Peitzsch, C., Charoudeh, H. N., Cheng, M., Chaves, P., Jacob-sen, S. E., et al. (2012). Emergence of NK-cell progenitors and functionally competent NK-cell lineage subsets in the early mouse embryo. Blood 120, 63-75.
54. Ting, C. N., Olson, M. C., Barton, K. P., and Leiden, J. M. (1996). Transcription factor GATA-3 is required for development of the T-cell lineage. Nature 384, 474-478.
55. Vargas, C. L., Poursine-Laurent, J., Yang, L., and Yokoyama, W. M. (2011). Development of thymic NK cells from double negative 1 thymocyte precursors. Blood 118, 3570-3578.
56. Vosshenrich, C. A., Cumano, A., Muller, W., Di Santo, J. P., and Vieira, P. (2003). Thymic stromal-derived lymphopoietin distinguishes fet al from adult B cell development. Nat. Immunol. 4, 773-779.
57. Vosshenrich, C. A., Garcia-Ojeda, M. E., Samson-Villeger, S. I., Pasqualetto, V., Enault, L., Richard-Le Goff, O., et al. (2006). A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD 127. Nat. Immunol. 7, 1217-1224.
58. Wang, J. H., Nichogiannopoulou, A., Wu, L., Sun, L., Sharpe, A. H., Bigby, M., et al. (1996). Selective defects in the development of the fet al and adult lymphoid system in mice with an Ikaros null mutation. Immunity 5, 537-549.
59. Warren, L. A., and Rothenberg, E. V. (2003). Regulatory coding of lymphoid lineage choice by hematopoietic transcription factors. Curr. Opin. Immunol. 15,166-175.
60. Yokota, Y., Mansouri, A., Mori, S., Sug-awara, S., Adachi, S., Nishikawa, S., et al. (1999). Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397, 702-706.
61. Yoshida, T., Ng, S. Y., Zuniga-Pflucker, J. C., and Georgopoulos, K. (2006). Early hematopoietic lineage restrictions directed by Ikaros. Nat. Immunol. 7,382-391.